Entrar Registro gratuito

Apellis Pharmaceuticals Inc Dinheiro/Ação

Qual é o Dinheiro/Ação de Apellis Pharmaceuticals Inc?

O Dinheiro/Ação de Apellis Pharmaceuticals Inc é 2.49

Qual é a definição de Dinheiro/Ação?

Dinheiro por ação é o dinheiro em caixa de uma empresa dividido pelas ações da empresa em circulação.

Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.

When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.

Dinheiro/Ação de empresas na Setor Health Care em NASDAQ em comparação com Apellis Pharmaceuticals Inc

O que Apellis Pharmaceuticals Inc faz?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Empresas com dinheiro/ação semelhantes a Apellis Pharmaceuticals Inc